Studies on the photostability and in vitro phototoxicity of Labetalol

Eur J Pharm Sci. 2001 Feb;12(4):495-504. doi: 10.1016/s0928-0987(00)00218-9.

Abstract

The purpose of this study was to obtain information on the photochemical and phototoxic properties of Labetalol, a beta-blocker drug. Preliminary information on the drug photoreactivity was achieved using a flow system with a photochemical reactor on-line with a diode array detection system. Photophysical and photochemical investigations on the drug were performed in aqueous solutions at different pH values using spectrophotometric and fluorimetric methods; the photodegradation quantum yield was found to be 2.7 x 10(-3) at pH 5.8 and 1.5 x 10(-2) at pH 11.5. Forced photodegradation of labetalol solutions under exposure to UVA--UVB radiations (xenon arc lamp) was monitored by reversed-phase liquid chromatography. The main photodegradation products were isolated and characterized by NMR and mass spectrometry; labetalol was found to give 3-amino-1-phenylbutane and salicylamide-4-carboxaldehyde as the main photoproducts. Preliminary phototoxic testings on human keratinocyte cultures were performed evaluating the viability of the cells by the neutral-red uptake assay; mutagenic and photomutagenicity tests were also carried out based on Salmonella typhimurium strains. As a result, labetalol was found to be photolabile,mainly in alkaline medium, but evidences of significant phototoxic and photomutagenic effects by the drug were not observed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3T3 Cells
  • Adrenergic beta-Antagonists / chemistry
  • Adrenergic beta-Antagonists / pharmacology*
  • Adrenergic beta-Antagonists / radiation effects
  • Animals
  • Cells, Cultured
  • Humans
  • Keratinocytes / drug effects*
  • Keratinocytes / radiation effects
  • Labetalol / chemistry
  • Labetalol / pharmacology*
  • Labetalol / radiation effects
  • Mice
  • Rats
  • Salmonella typhimurium / drug effects*
  • Salmonella typhimurium / radiation effects
  • Ultraviolet Rays* / adverse effects

Substances

  • Adrenergic beta-Antagonists
  • Labetalol